Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer

PURPOSE: Chemotherapeutic adjuvants, such as oxaliplatin (OXA) and 5-fluorouracil (5-FU), that enhance the immune system, are being assessed as strategies to improve durable response rates when used in combination with immune checkpoint inhibitor (ICI) monotherapy in cancer patients. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggi, Julian L, Hartimath, Siddesh V, Xuan, Tan Yun, Khanapur, Shivashankar, Jieu, Beverly, Chin, Hui Xian, Ramasamy, Boominathan, Cheng, Peter, Rong, Tang Jun, Fong, Yong Fui, Yuen, Tsz Ying, Msallam, Rasha, Chacko, Ann-Marie, Renia, Laurent, Johannes, Charles, Hwang, You Yi, Robins, Edward G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410722/
https://www.ncbi.nlm.nih.gov/pubmed/33713000
http://dx.doi.org/10.1007/s11307-021-01596-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410722/
https://www.ncbi.nlm.nih.gov/pubmed/33713000
http://dx.doi.org/10.1007/s11307-021-01596-y

Ejemplares similares